取消
清空記錄
歷史記錄
清空記錄
歷史記錄
產(chǎn)品中心
瀏覽器自帶分享功能也很好用哦~貨號：HY-B0215
CAS：616-91-1
在線客服
客服一
Acetylcysteine (Synonyms: 乙酰半胱氨酸）
Acetylcysteine (N-Acetylcysteine) 是一種粘液溶解劑 (mucolytic agent)，可用于減少粘液的厚度。Acetylcysteine 是一種 ROS 抑制劑。Acetylcysteine 是半胱氨酸前體，通過中和花生四烯酸依賴的5-脂氧合酶活性所產(chǎn)生的毒性脂質(zhì)來防止血紅素誘導的鐵中毒 (ferroptosis)。Acetylcysteine 可以誘導細胞凋亡 (apoptosis)，并具有抗流感病毒活性。
生物活性
Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor[1]. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases[5]. Acetylcysteine induces cell apoptosis[2][3]. Acetylcysteine also has anti-influenza virus activities[7].
IC50 & Target
Human Endogenous Metabolite
體外研究(In Vitro)
Acetylcysteine prevents apoptotic DNA fragmentation and maintains long-term survival in the absence of other trophic support in serum-deprived PC12 cells. Acetylcysteine also prevents death of PC12 cells and sympathetic neurons[2].
Acetylcysteine causes dose-dependent reductions in viability in rat and human aortic smooth muscle cells[3].
Acetylcysteine activates the Ras-extracellular signal-regulated kinase (ERK) pathway in PC12 cells. Acetylcysteine protects neuronal cells from death evoked by withdrawal of trophic support. Acetylcysteine increases nitric oxide (NO) release from protein-bound stores in vascular tissue. Acetylcysteine pretreatment of PC12 cells interferes with NGF-dependent signaling and neurite outgrowth, and it is suggested that Acetylcysteine interferes with redox-sensitive steps in the NGF mechanism[4].
體內(nèi)研究(In Vivo)
Acetylcysteine (150, 300 mg/kg) treatment significantly reduces liver transaminases in all groups of treatment, mostly in group Acetylcysteine 300. Lung glutathione peroxidase is significantly increases in group Acetylcysteine 300 (P=0.04), while the other oxidation biomarkers show no significant differences[6].
Acetylcysteine improves cognition of 12-month-old SAMP8 mice in both the T-maze footshock avoidance paradigm and the lever press appetitive task without inducing non-specific effects on motor activity, motivation to avoid shock, or body weight[5].
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT03708458 | Grigore T. Popa University of Medicine and Pharmacy | April 1, 2017 | Phase 4 | |
| NCT00532688 | Bayside Health|The Alfred | September 2007 | Phase 2|Phase 3 | |
| NCT04368598 | Peking University People′s Hospital | April 1, 2019 | Phase 2 |
分子量：163.19
Formula：C5H9NO3S
CAS 號：616-91-1
中文名稱：乙酰半胱氨酸
運輸條件：Room temperature in continental US; may vary elsewhere.
儲存方式：
4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性數(shù)據(jù)
DMSO : ≥ 130 mg/mL (796.62 mM)
H2O : 50 mg/mL (306.39 mM; Need ultrasonic)
* "≥" means soluble, but saturation unknown.
| 濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.1278 mL | 30.6391 mL | 61.2783 mL |
| 5 mM | 1.2256 mL | 6.1278 mL | 12.2557 mL |
| 10 mM | 0.6128 mL | 3.0639 mL | 6.1278 mL |
請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；一旦配成溶液，請分裝保存，避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲存時，請在 6 個月內(nèi)使用，-20°C 儲存時，請在 1 個月內(nèi)使用。
以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液，再依次添加助溶劑：
——為保證實驗結(jié)果的可靠性，澄清的儲備液可以根據(jù)儲存條件，適當保存；體內(nèi)實驗的工作液，建議您現(xiàn)用現(xiàn)配，當天使用； 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的方式助溶
- 1.
請依序添加每種溶劑： PBS
Solubility: 120 mg/mL (735.34 mM); Clear solution; Need ultrasonic
參考文獻
貨號：HY-B0215
CAS：616-91-1
在線客服客服一Acetylcysteine (Synonyms: 乙酰半胱氨酸）
Acetylcysteine (N-Acetylcysteine) 是一種粘液溶解劑 (mucolytic agent)，可用于減少粘液的厚度。Acetylcysteine 是一種 ROS 抑制劑。Acetylcysteine 是半胱氨酸前體，通過中和花生四烯酸依賴的5-脂氧合酶活性所產(chǎn)生的毒性脂質(zhì)來防止血紅素誘導的鐵中毒 (ferroptosis)。Acetylcysteine 可以誘導細胞凋亡 (apoptosis)，并具有抗流感病毒活性。
生物活性
Acetylcysteine (N-Acetylcysteine) is a mucolytic agent which reduces the thickness of the mucus. Acetylcysteine is a ROS inhibitor[1]. Acetylcysteine is a cysteine precursor, prevents hemin-induced ferroptosis by neutralizing toxic lipids generated by arachidonate-dependent activity of 5-lipoxygenases[5]. Acetylcysteine induces cell apoptosis[2][3]. Acetylcysteine also has anti-influenza virus activities[7].
IC50 & Target
Human Endogenous Metabolite
體外研究(In Vitro)
Acetylcysteine prevents apoptotic DNA fragmentation and maintains long-term survival in the absence of other trophic support in serum-deprived PC12 cells. Acetylcysteine also prevents death of PC12 cells and sympathetic neurons[2].
Acetylcysteine causes dose-dependent reductions in viability in rat and human aortic smooth muscle cells[3].
Acetylcysteine activates the Ras-extracellular signal-regulated kinase (ERK) pathway in PC12 cells. Acetylcysteine protects neuronal cells from death evoked by withdrawal of trophic support. Acetylcysteine increases nitric oxide (NO) release from protein-bound stores in vascular tissue. Acetylcysteine pretreatment of PC12 cells interferes with NGF-dependent signaling and neurite outgrowth, and it is suggested that Acetylcysteine interferes with redox-sensitive steps in the NGF mechanism[4].
體內(nèi)研究(In Vivo)
Acetylcysteine (150, 300 mg/kg) treatment significantly reduces liver transaminases in all groups of treatment, mostly in group Acetylcysteine 300. Lung glutathione peroxidase is significantly increases in group Acetylcysteine 300 (P=0.04), while the other oxidation biomarkers show no significant differences[6].
Acetylcysteine improves cognition of 12-month-old SAMP8 mice in both the T-maze footshock avoidance paradigm and the lever press appetitive task without inducing non-specific effects on motor activity, motivation to avoid shock, or body weight[5].
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT03708458 | Grigore T. Popa University of Medicine and Pharmacy | April 1, 2017 | Phase 4 | |
| NCT00532688 | Bayside Health|The Alfred | September 2007 | Phase 2|Phase 3 | |
| NCT04368598 | Peking University People′s Hospital | April 1, 2019 | Phase 2 |
分子量：163.19
Formula：C5H9NO3S
CAS 號：616-91-1
中文名稱：乙酰半胱氨酸
運輸條件：Room temperature in continental US; may vary elsewhere.
儲存方式：
4°C, protect from light
*In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
溶解性數(shù)據(jù)
DMSO : ≥ 130 mg/mL (796.62 mM)
H2O : 50 mg/mL (306.39 mM; Need ultrasonic)
* "≥" means soluble, but saturation unknown.
| 濃度溶劑體積質(zhì)量 | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 6.1278 mL | 30.6391 mL | 61.2783 mL |
| 5 mM | 1.2256 mL | 6.1278 mL | 12.2557 mL |
| 10 mM | 0.6128 mL | 3.0639 mL | 6.1278 mL |
請根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲備液；一旦配成溶液，請分裝保存，避免反復凍融造成的產(chǎn)品失效。
儲備液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (protect from light)。-80°C 儲存時，請在 6 個月內(nèi)使用，-20°C 儲存時，請在 1 個月內(nèi)使用。
以下溶解方案都請先按照 In Vitro 方式配制澄清的儲備液，再依次添加助溶劑：
——為保證實驗結(jié)果的可靠性，澄清的儲備液可以根據(jù)儲存條件，適當保存；體內(nèi)實驗的工作液，建議您現(xiàn)用現(xiàn)配，當天使用； 以下溶劑前顯示的百
分比是指該溶劑在您配制終溶液中的體積占比；如在配制過程中出現(xiàn)沉淀、析出現(xiàn)象，可以通過加熱和/或超聲的方式助溶
- 1.
請依序添加每種溶劑： PBS
Solubility: 120 mg/mL (735.34 mM); Clear solution; Need ultrasonic
參考文獻
取消
清空記錄
歷史記錄
清空記錄
歷史記錄
